| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Investigations |
Laboratoire du Cytosquelette, Institut National de la Santé et de la Recherche Médicale (INSERM) U366, Département de Biologie Molèeculaire et Structurale, Commissariat á lEnergie Atomique, 38054 Grenoble Cedex 9, France [A. M., L. L., D. J.]; Département dAnatomie et de Cytologie Pathologiques, Centre Léon Bérard, 69373 Lyon, France [I. T., N. P., C. D., A. B.]; Clinique Belledonne, 38400 Saint Martin dHèeres, France [M. H. P., R. P.]; Gesellschaft für Biotechnologische Forschung mbH, 38092 Braunschweig, Germany [J. W.]; and Institut de Biologie Structurale J. P. Ebel (Commissariat á lEnergie Atomique-Centre National de la Recherche Scientifique), 38027 Grenoble Cedex 1, France [R. L. M.]
Tubulin, the dimeric subunit of microtubules, is a major cell protein that is centrally involved in cell division. Tubulin is subject to specific enzymatic posttranslational modifications including cyclic tyrosine removal and addition at the COOH terminus of the
-subunit. Tubulin is normally extensively tyrosinated in cycling cells. However, we have previously shown that detyrosinated tubulin accumulates in cancer cells during tumor progression in nude mice. Tubulin detyrosination, resulting from suppression of tubulin tyrosine ligase and the resulting unbalanced activity of tubulin-carboxypeptidase, apparently represents a strong selective advantage for cancer cells. We have now analyzed the occurrence and significance of tubulin detyrosination in human breast tumors. We studied a total of 134 breast cancer tumors from patients with or without known complications over a follow-up period of 31 ± 10 months. The mean age of the patients at the time of diagnosis was 57 years. For each patient, detailed data concerning the histology and extension of the tumor were available. Tumor cells containing detyrosinated tubulin were visualized by immunohistochemical staining of paraffin-embedded tissue sections.
Cancer cells with detyrosinated tubulin were observed in 53% of the tumors and were predominant in 19.4% of the tumors. Tubulin detyrosination correlated to a high degree of significance (P < 0.001) with a high Scarf-Bloom-Richardson (SBR) grade, a known marker of tumor aggressiveness. Among SBR grade 1 tumors, 3.8% were strongly positive for tubulin detyrosination compared with 65.4% of the SBR grade 3 tumors. The SBR component showing the strongest correlation with tubulin detyrosination was the mitotic score. In the entire patient population, neither the SBR grade nor the detyrosination index had significant prognostic value (P = 0.11, P = 0.27, respectively), whereas a combined index was significantly correlated with the clinical outcome (P = 0.02). A preliminary subgroup analysis indicated that tubulin detyrosination may define high- and low- risk groups in breast cancer tumors with an SBR grade of 2. Our study shows that tubulin detyrosination is a frequent occurrence in breast cancer, easy to detect, and linked to tumor aggressiveness.
This article has been cited by other articles:
![]() |
L. Peris, M. Wagenbach, L. Lafanechere, J. Brocard, A. T. Moore, F. Kozielski, D. Job, L. Wordeman, and A. Andrieux Motor-dependent microtubule disassembly driven by tubulin tyrosination J. Cell Biol., June 29, 2009; 185(7): 1159 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zekert and R. Fischer The Aspergillus nidulans Kinesin-3 UncA Motor Moves Vesicles along a Subpopulation of Microtubules Mol. Biol. Cell, January 1, 2009; 20(2): 673 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Whipple, E. M. Balzer, E. H. Cho, M. A. Matrone, J. R. Yoon, and S. S. Martin Vimentin Filaments Support Extension of Tubulin-Based Microtentacles in Detached Breast Tumor Cells Cancer Res., July 15, 2008; 68(14): 5678 - 5688. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Barco, L. B. Hunt, A. L. Frump, C. B. Garcia, A. Benesh, R. L. Caldwell, and J. E. Eid The Synovial Sarcoma SYT-SSX2 Oncogene Remodels the Cytoskeleton through Activation of the Ephrin Pathway Mol. Biol. Cell, October 1, 2007; 18(10): 4003 - 4012. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fonrose, F. Ausseil, E. Soleilhac, V. Masson, B. David, I. Pouny, J.-C. Cintrat, B. Rousseau, C. Barette, G. Massiot, et al. Parthenolide Inhibits Tubulin Carboxypeptidase Activity Cancer Res., April 1, 2007; 67(7): 3371 - 3378. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Vandermoere, I. E. Yazidi-Belkoura, Y. Demont, C. Slomianny, J. Antol, J. Lemoine, and H. Hondermarck Proteomics Exploration Reveals That Actin Is a Signaling Target of the Kinase Akt Mol. Cell. Proteomics, January 1, 2007; 6(1): 114 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Peris, M. Thery, J. Faure, Y. Saoudi, L. Lafanechere, J. K. Chilton, P. Gordon-Weeks, N. Galjart, M. Bornens, L. Wordeman, et al. Tubulin tyrosination is a major factor affecting the recruitment of CAP-Gly proteins at microtubule plus ends J. Cell Biol., September 11, 2006; 174(6): 839 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Erck, L. Peris, A. Andrieux, C. Meissirel, A. D. Gruber, M. Vernet, A. Schweitzer, Y. Saoudi, H. Pointu, C. Bosc, et al. A vital role of tubulin-tyrosine-ligase for neuronal organization PNAS, May 31, 2005; 102(22): 7853 - 7858. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Low, S. B. Wedam, J. J. Lee, A. W. Berman, A. Brufsky, S. X. Yang, M. S. Poruchynsky, S. M. Steinberg, N. Mannan, T. Fojo, et al. Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Metastatic and Locally Advanced Breast Cancer J. Clin. Oncol., April 20, 2005; 23(12): 2726 - 2734. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-O. Yoon, S. Shin, and A. M. Mercurio Hypoxia Stimulates Carcinoma Invasion by Stabilizing Microtubules and Promoting the Rab11 Trafficking of the {alpha}6{beta}4 Integrin Cancer Res., April 1, 2005; 65(7): 2761 - 2769. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Unwin, D. W. Sternberg, Y. Lu, A. Pierce, D. G. Gilliland, and A. D. Whetton Global Effects of BCR/ABL and TEL/PDGFR{beta} Expression on the Proteome and Phosphoproteome: IDENTIFICATION OF THE RHO PATHWAY AS A TARGET OF BCR/ABL J. Biol. Chem., February 25, 2005; 280(8): 6316 - 6326. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bloom Microtubule composition: Cryptography of dynamic polymers PNAS, May 4, 2004; 101(18): 6839 - 6840. [Full Text] [PDF] |
||||
![]() |
A. C. Badin-Larcon, C. Boscheron, J. M. Soleilhac, M. Piel, C. Mann, E. Denarier, A. Fourest-Lieuvin, L. Lafanechere, M. Bornens, and D. Job From the Cover: Suppression of nuclear oscillations in Saccharomyces cerevisiae expressing Glu tubulin PNAS, April 13, 2004; 101(15): 5577 - 5582. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |